Cargando…

Bruton tyrosine kinase inhibitors as potential therapeutic agents for COVID-19: A review

Coronavirus disease 2019 (COVID-19) is first detected in December 2019 in Wuhan, China which is a new pandemic caused by SARS-COV-2 that has greatly affected the whole world. Bruton tyrosine kinase (BTK) inhibitors are drugs that are used for the management of cancer, and are being repurposed for CO...

Descripción completa

Detalles Bibliográficos
Autor principal:	Kifle, Zemene Demelash
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Articles from the Vaccines, Immune Response, Therapeutic Interventions and COVID-19 Special Issue
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318668/ https://www.ncbi.nlm.nih.gov/pubmed/34345815 http://dx.doi.org/10.1016/j.metop.2021.100116

Ejemplares similares

Herbal medicine use for the management of COVID-19: A review article
por: Demeke, Chilot Abiyu, et al.
Publicado: (2021)

Roles of existing drug and drug targets for COVID-19 management
por: Ayele, Akeberegn Gorems, et al.
Publicado: (2021)

Perspectives in vaccines, immune response, therapeutic interventions and COVID-19
por: Karampela, Irene
Publicado: (2022)

SARS-CoV-2 and diabetes: A potential therapeutic effect of dipeptidyl peptidase 4 inhibitors in diabetic patients diagnosed with COVID-19
por: Kifle, Zemene Demelash, et al.
Publicado: (2021)

COVID-19 vaccines: Current evidence and considerations
por: Tavilani, Alireza, et al.
Publicado: (2021)

The effect of COVID-19 pandemic on the attendance and clinical outcomes of patients with ophthalmic disease: A mini-review
por: Syriga, Maria, et al.
Publicado: (2021)

Serious complications of COVID-19 vaccines: A mini-review
por: Fragkou, Paraskevi C., et al.
Publicado: (2021)

Diabetes and COVID-19: Mechanism of pneumonia, treatment strategy and vaccine
por: Abbasi, Ebrahim, et al.
Publicado: (2021)

A systematic review on the effects of Echinacea supplementation on cytokine levels: Is there a role in COVID-19?
por: Aucoin, Monique, et al.
Publicado: (2021)

Thyroiditis following vaccination against COVID-19: Report of two cases and review of the literature
por: Siolos, Athanasios, et al.
Publicado: (2021)

Herpes zoster following COVID-19 vaccination in an immunocompetent and vaccinated for herpes zoster adult: A two-vaccine related event?
por: Vallianou, Natalia G., et al.
Publicado: (2022)

Breakthrough infections after COVID-19 vaccination: Insights, perspectives and challenges
por: Amanatidou, Evropi, et al.
Publicado: (2022)

Vaccine induced thrombotic thrombocytopenia: The shady chapter of a success story
por: Tsilingiris, Dimitrios, et al.
Publicado: (2021)

Major cardiac concerns in therapy and vaccinations for COVID-19
por: Junapudi, Syam Sundar, et al.
Publicado: (2021)

Anti-viral treatment for SARS-CoV-2 infection: A race against time amidst the ongoing pandemic
por: Vallianou, Natalia G., et al.
Publicado: (2021)

Saffron for “toning down” COVID-19-related cytokine storm: Hype or hope? A mini-review of current evidence
por: Mentis, Alexios-Fotios A., et al.
Publicado: (2021)

The impact of dawn to sunset fasting on immune system and its clinical significance in COVID-19 pandemic
por: Bhatti, Sundus I., et al.
Publicado: (2021)

Potential implications of lipid nanoparticles in the pathogenesis of myocarditis associated with the use of mRNA vaccines against SARS-CoV-2
por: Tsilingiris, Dimitrios, et al.
Publicado: (2021)

A review on protective roles and potential mechanisms of metformin in diabetic patients diagnosed with COVID-19
por: Kifle, Zemene Demelash, et al.
Publicado: (2021)

Post COVID-19 Vaccination Side Effects and Associated Factors Among Vaccinated Clients in Bahir Dar City, Ethiopia
por: Siraj, Ebrahim Abdela, et al.
Publicado: (2023)

Humoral antibody kinetics with ChAdOx1-nCOV (Covishield™) and BBV-152 (Covaxin™) vaccine among Indian Healthcare workers: A 6-month longitudinal cross-sectional Coronavirus Vaccine-induced antibody titre (COVAT) study
por: Singh, Awadhesh Kumar, et al.
Publicado: (2022)

Second-generation inhibitors of Bruton tyrosine kinase
por: Wu, Jingjing, et al.
Publicado: (2016)

Bruton tyrosine kinase inhibitors for multiple sclerosis
por: Krämer, Julia, et al.
Publicado: (2023)

Novel Bruton’s tyrosine kinase inhibitors currently in development
por: D’Cruz, Osmond J, et al.
Publicado: (2013)

Editorial: New Insights on Bruton’s Tyrosine Kinase Inhibitors
por: Smith, C. I. Edvard, et al.
Publicado: (2021)

The Use of Bruton Tyrosine Kinase Inhibitors in Waldenström’s Macroglobulinemia
por: Khan, Abdullah Mohammad
Publicado: (2022)

The Use of Bruton Tyrosine Kinase Inhibitors in Waldenström’s Macroglobulinemia
por: Ababneh, Obada, et al.
Publicado: (2022)

Bruton tyrosine kinase inhibitors in the management of Waldenström macroglobulinemia
por: Castillo, Jorge J., et al.
Publicado: (2023)

Bruton’s tyrosine kinase inhibitors in the treatment of multiple sclerosis
por: Shulga, Olga, et al.
Publicado: (2023)

Bruton’s Tyrosine Kinase Inhibitors: A New Therapeutic Target for the Treatment of SLE?
por: Lorenzo-Vizcaya, Ana, et al.
Publicado: (2020)

The Use of Bruton’s Tyrosine Kinase Inhibitors to Treat Allergic Disorders
por: Dispenza, Melanie C.
Publicado: (2021)

Bruton's tyrosine kinase: oncotarget in myeloma
por: Tai, Yu-Tzu, et al.
Publicado: (2012)

Editorial: Targeting Bruton Tyrosine Kinase
por: Brunner, Cornelia, et al.
Publicado: (2022)

Targeting Bruton’s Tyrosine Kinase in CLL
por: Ahn, Inhye E., et al.
Publicado: (2021)

Colchicine as a Potential Therapeutic Agent Against Cardiovascular Complications of COVID-19: an Exploratory Review
por: Papadopoulos, Christodoulos, et al.
Publicado: (2020)

Bruton’s Tyrosine Kinase Inhibitors: A New Generation of Promising Agents for Multiple Sclerosis Therapy
por: García-Merino, Antonio
Publicado: (2021)

An endoluminal cylindrical sectored‐ring ultrasound phased‐array applicator for minimally‐invasive therapeutic ultrasound
por: Zubair, Muhammad, et al.
Publicado: (2022)

PI3Kγ kinase activity is required for optimal T-cell activation and differentiation
por: Ladygina, Nadia, et al.
Publicado: (2013)

Potential use of 3-(trimethoxysilyl)propyldimethyl octadecyl ammonium chloride as an antimicrobial and antiviral agent for the disinfection of personal protective equipment
por: Kim, Yujin, et al.
Publicado: (2020)

Bruton’s tyrosine kinase is a possible therapeutic target in microscopic polyangiitis
por: Nakade, Issei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_m3chlhpuusikba0qho68bq410f